HIMS Stock Surges 11% to $27 as FDA Review Sparks Peptide Market Rally
Hims & Hers Health (NYSE: HIMS) surged sharply in Thursday trading, climbing to $27.14, up +11.71% intraday, as investors reacted to a fresh regulatory development that could reshape the future…







